Lead risk assessment

Absorbed lead is distributed in various tissue compartments. Several models of lead pharmacokinetics have been proposed to characterize such parameters as intercompartmental lead exchange rates, retention of lead in various pools, and relative rates of distribution among the tissue groups. See Section 2.3.5 for a discussion of the classical compartmental models and physiologically based pharmacokinetic models (PBPK) developed for lead risk assessments. 

PBPK and classical pharmacokinetic models both have valid applications in lead risk assessment. Both approaches can incorporate capacity-limited or nonlinear kinetic behavior in parameter estimates. An advantage of classical pharmacokinetic models is that, because the kinetic characteristics of the compartments of which they are composed are not constrained, a best possible fit to empirical data can be arrived at by varying the values of the parameters (O Flaherty 1987). However, such models are not readily extrapolated to other species because the parameters do not have precise physiological correlates. Compartmental models developed to date also do not simulate changes in bone metabolism, tissue volumes, blood flow rates, and enzyme activities associated with pregnancy, adverse nutritional states, aging, or osteoporotic diseases. Therefore, extrapolation of classical compartmental model simulations... 

Keywords DeBDE, E-waste, Human Health, Lead, Risk Assessment... 

Although biomonitoring data constitute a key body of knowledge about the distribution of exposure, relatively few risk assessments have been based on biomarker-response relationships established in epidemiologic studies (WHO 2001). In a recent informal survey of leading risk-assessment prac-... 

Predictive Pb exposure models serve various pmposes in lead environmental epidemiology and human lead risk assessments. For example, weU-validated mechanistic, i.e., biokinetic, models can generate outputs that substitute for measurement data where gathering measurements may not be feasible or even possible. These constraints arise from realities of resource limits, poor subject accessibility, or inappropriate timing for gathering the... 

An earlier discussion in this book concerned the interactive relationship of lead research and lead regulatory and health policy (Mushak, 1991 NAS/ NRC, 1993). This part on health risk assessment for lead demonstrates an analogous relationship for research and risk assessment as depicted in Figure 20.1. New scientific research data on lead toxicology and epidemiology are used to quantify lead risk assessment. Remaining research gaps in... 

The lEUBK model is currently the standard risk assessment tool by which Federal and state lead risk assessments are carried out at Pb exposure sites with young children potentially exposed. Reliance on predictive modeling rather than requiring sole use of PbB screening of impacted children is driven in large part because of those concerns. 

In any patient with documented LEAD, risk assessment for cerebrovascular, and coronary heart disease of utmost importance. 

Risk-Based Inspection. Inspection programs developed using risk analysis methods are becoming increasingly popular (15,16) (see Hazard ANALYSIS AND RISK ASSESSMENT). In this approach, the frequency and type of in-service inspection (IS I) is determined by the probabiUstic risk assessment (PRA) of the inspection results. Here, the results might be a false acceptance of a part that will fail as well as the false rejection of a part that will not fail. Whether a plant or a consumer product, false acceptance of a defective part could lead to catastrophic failure and considerable cost. Also, the false rejection of parts may lead to unjustified, and sometimes exorbitant, costs of operation (2). Risk is defined as follows ... 

The analysis of a risk—that is, its estimation—leads to the assessment of that risk and the decision-making processes of selecting the appropriate level of risk reduction. In most studies this is an iterative process of risk analysis and risk assessment until the risk is reduced to some specified level. The subjec t of acceptable or tolerable levels of risk that coiild be applied to decision making on risks is a complex subject which will not oe addressed in this section. 

Requirements for protecting the health of workers exposed to lead including lead alloys, lead compounds and lead containing substances. A risk assessment is necessary. 

When the exposure is well below the limit values and it is possible to be confident that on a long-term basis the probability of exceeding the limit value is very low, the risk assessment may conclude that the nature and extent of the risks related to those chemical agents make a further detailed risk assessment unnecessary unless work conditions are modified in a significant way. In these cases, however, it must be regularly checked w hether the assessment leading to that conclusion is still applicable. 

This chapter has provided an overview of a recommended framework for the assessment of human error in chemical process risk assessments. The main emphasis has been on the importance of a systematic approach to the qualitative modeling of human error. This leads to the identification and possible reduction of the human sources of risk. This process is of considerable value in its own right, and does not necessarily have to be accompanied by the quantification of error probabilities. 

The reader should note tliat since many risk assessments have been conducted on the basis of fatal effects, there are also uncertainties on precisely what constitutes a fatal dose of thennal radiation, blast effect, or a toxic chemical. Where it is desired to estimate injuries as well as fatalities, tlie consequence calculation can be repeated using lower intensities of exposure leading to injury rather titan dcatli. In addition, if the adverse healtli effect (e.g. associated with a chemical release) is delayed, the cause may not be obvious. Tliis applies to both chronic and acute emissions and exposures. 

Envlroiunental testing Is a critical element In this process since It enables the qualitative and quantitative determination of toxic chemicals In the environment and the definition of environmental pathways which may lead to human exposure This paper briefly reviews the overall process of health risk assessments and the particular role which environmental testing plays Recent efforts to assess environmental health risks In relation to Love Canal Illustrate both the usefulness and the limitations of environmental testing In risk assessment ... 

In terms of environmental metrics to assess processes, it is hopefully clear that a considerable testing burden exists to assess potential environmental hazards that lead to a credible risk assessment. At a first pass, one would typically screen compounds from an environmental hazard perspective to assess their tendency for persistence, bioaccumulation and toxicity. Depending on the final application of the compoimd, one might avoid commercial production of a particular compound, or one might devise processes that would use the... 

The first step in a process plant building risk assessment is to identify specific accident scenarios that endanger building occupants. As discussed in Chapter 2 and illustrated in Table 2.1, accident scenarios are sequences of events that lead to an outcome of concern. The specific outcomes of concern are those involving explosions or fires that could impact buildings in process plants. 

The risk assessment has also concluded that a level of 200 mg/kg for lead in the soil will be a protective level for expected site exposures along with an excess cancer risk level for TCE-contaminated soil (56 pg/L). Based on investigations of activities at the site, the TCE-contaminated soil has not been determined to be a listed RCRA hazardous waste, as the cleaning solution records indicate the solution contained less than 10% TCE. However, the lead-contaminated soil is an RCRA hazardous waste by characteristic in this instance due to extraction procedure (EP) toxicity. None of the waste is believed to have been disposed at the site after November 19, 1980 (the effective date for most of the RCRA treatment, storage, and disposal requirements). 

It is advisable, then, in a tiered approach to concentrate first on crops and activities (scenarios) that are considered to be relevant with respect to the expected level of exposure and to exclude those not relevant. Second, whether or not the toxicological properties of the product may lead to general restrictions on re-entry should be investigated. If both the likelihood of reentry and the hazard due to the toxicity of the compound cannot generally be neglected, a risk assessment over several steps should be carried out. The assessment may be based on surrogate data and "worst-case" assumptions at first and then refined, if necessary. One possible approach to a tiered evaluation procedure is presented in Figure 1. 

If linear (dose) models without thresholds are to be used for carcinogen (or other) risk assessment, estimation of exposure at specified levels becomes irrelevant to risk assessment or, at least, its use is nonintuitive. For example, a carcinogen risk analysis may be based on a linear, nonthreshold health effects model. The total health risk would thus be proportional to the long-term exposure summed for all affected people for the identified period, and exposure of many people at low concentrations would be equivalent to exposure of a few to high concentrations. The atmospheric dispersion that reduces concentrations would also lead to exposure of more people therefore, increments... 

For PBPK models for lead, the overall results and individual models are discussed in this section in terms of their use in risk assessment, tissue dosimetry, dose, route, and species extrapolations. 

The O Flaherty Model simulates the age-dependence of lead kinetics on such factors as absorption efficiency, excretion efficiency, uptake into bone and loss from bone, and partitioning between plasma and red blood cells. The model does not incorporate age, dose rate, or time dependence of lead accumulation in every organ (e g., kidney) because the complex patterns of lead accumulation in certain tissues are not known (O Flaherty 1991a) (see Section 2.4.1). However, the basic model structure allows for additional modules to be incorporated, depending on its intended use in risk assessment. For example, additional modules that are currently being developed are a pregnancy model and a model of net bone loss in older women and men. 

---